No offense to “new eyes”, Doc, but Joe needs to come thru with significant, material progress in the next week or so... or some of the “old eyes”, including mine, are going to start moving on as well.

I won’t completely bail, but my time with this stock as a primary focus is quickly drawing to a close without forward progress in the month of July.

We’ve been dragging this hopper full of great things around for far too long with one or two real arrows in our quiver. Excellagen is apparently sidelined due to CV, so it’s really up to realizing the “hundreds of millions” from NGIO or getting one of the half dozen financing packages off the shelf and into reality.

Let’s see the best of what you’ve been working on on Friday, Joe. This is a critical time.